Purity ≥ 99%CJC-1295 + Ipamorelin Peptide blend
- CJC-1295 (without DAC)
- Ipamorelin
Each bottle contains 5mg CJC-1295 (no DAC) + 5mg Ipamorelin. Analytical-grade peptide reference material, supplied as a lyophilized powder for in-vitro laboratory research use only.
Bundle and bulk savings, codes and shipping are worked out in the cart at VNG.
Free shipping over $149 · CoA included with every order
What it is
A research stack pairing a GHRH analog (CJC-1295) with a selective growth-hormone secretagogue (Ipamorelin).
How it is studied
The two act on different receptors — one mimics GHRH, the other the ghrelin/GHS receptor — so research studies their synergistic effect on growth-hormone release, while Ipamorelin's selectivity limits off-target signaling.
Research areas
Growth-hormone-axis and recovery research.
Lab report for every lot
Each lot ships with a Certificate of Analysis matched to its lot number: purity, identity, heavy metals, sterility and endotoxin.
Published research
- Ipamorelin and chemotherapy weight loss — animal studyPhysiology & behavior, 2024
- Ipamorelin — first selective GH secretagogueEuropean journal of endocrinology, 1998
- Therapeutic peptides in orthopaedics — reviewJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026
- Ipamorelin and bone growth — ratsGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1999
- Ipamorelin pharmacokinetics in human volunteersPharmaceutical research, 1999
- Ipamorelin pharmacokinetics & nasal absorptionXenobiotica; the fate of foreign compounds in biological systems, 1998
- GH secretagogue hybrids of ipamorelin — chemistryBioorganic & medicinal chemistry letters, 2001
- GH secretagogues and body composition — reviewTranslational andrology and urology, 2020
Research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
